8-KFiling Date: May 11, 2026

Moderna (MRNA) 8-K: Bylaw Amendment, Shareholder Vote (May 11, 2026)

mrna-20260506

Event Type

Bylaw AmendmentShareholder VoteFinancial Statements

Filing overview

Moderna (MRNA) filed a Form 8-K (Material Event (8-K)) with the SEC on 2026-05-11. Reported items: Item 5.03 Bylaw Amendment; Item 5.07 Shareholder Vote; Item 9.01 Financial Statements.

More filings from Moderna (MRNA)

Moderna (MRNA) 8-K · Sep 30, 2026Executive Change; Reg FD Disclosure; Financial Statements
Moderna (MRNA) 8-K · Sep 1, 2026Material Agreement; Financial Obligation; Securities Issuance; Other…
Moderna (MRNA) 10-Q · Jul 31, 2026Quarterly Report · ended 2026-06-30 · Rev $145.0M, NI -$782.0M
Moderna (MRNA) 8-K · Jul 31, 2026Earnings Release; Financial Statements
Moderna (MRNA) 8-K · Jul 8, 2026Former Biogen CFO joins board
Moderna (MRNA) 10-Q · May 1, 2026

Recent 8-K filings from other companies

Corteva (CTVA) 8-K · Oct 5, 2026Material Agreement; Acquisition/Disposition; Financial Statements
Apollo Global Management 8-K · Oct 5, 2026Earnings Release; Reg FD Disclosure
SOLAREDGE TECHNOLOGIES, INC. (SEDG) 8-K · Oct 5, 2026CRO resigns, no successor named
Pinterest (PINS) 8-K · Oct 5, 2026Pinterest hires Amazon exec as CFO
Bunge Global (BG) 8-K · Oct 5, 2026Executive Change; Financial Statements